U.S. denounces terms for WHO-led inquiry into coronavirus origins

The United States said on Tuesday that the terms under which a World Health Organization-led team of experts is to investigate the origins of the new coronavirus were not transparently negotiated or in line with the mandate agreed by member states.

Oxford ups COVID-19 testing capacity with Thermo Fisher deal

The University of Oxford has partnered with U.S.-based Thermo Fisher Scientific to ramp up its capacity to deliver COVID-19 testing data and help collect and quantify immune responses in its vaccine trials, the university said on Tuesday.

Brazil suspends Sinovac COVID-19 vaccine trial due to severe adverse event

Brazil's health regulator has suspended a clinical trial for China's Sinovac coronavirus vaccine citing a severe adverse event, surprising the trial organisers who countered there had been a death but it was unrelated to the vaccine.

Brazil's Bolsonaro claims Sinovac vaccine trial suspension as a 'victory'

Brazil's President Jair Bolsonaro on Tuesday claimed the suspension of a clinical trial for China's Sinovac coronavirus vaccine as "another victory" for him personally, he said in a post on his Facebook page.

What you need to know about the coronavirus right now

Here's what you need to know about the coronavirus right now:

U.S. COVID-19 hospitalizations surge to record of just over 59,000 patients: Reuters tally

There were just over 59,000 COVID-19 patients in hospitals across the United States on Monday, the country's highest number ever of in-patients being treated for the disease, with new infections at record levels for the sixth consecutive day.

BioNTech to price vaccine below market rates, differentiate between regions

BioNTech, first in the race to produce evidence of a working COVID-19 vaccine, is planning to price the two-shot regimen below "typical market rates" and would differentiate pricing between countries or regions.

Botswana signs agreement with global vaccine scheme for 20% of population

Botswana has signed an agreement with the global vaccine distribution scheme co-led by the World Health Organization, giving it the option to buy coronavirus vaccines for 20% of its population, a senior health official told Reuters.

Pfizer vaccine trial success signals breakthrough in pandemic battle

Pfizer Inc's experimental COVID-19 vaccine is more than 90% effective based on initial trial results, the drugmaker said on Monday, a major victory in the war against a virus that has killed over a million people and battered the world's economy.

Biden says vaccine approval process must be guided by science

President-elect Joe Biden on Monday said a coronavirus vaccine approval process must be guided by science so the public can have confidence it is safe and effective, warning that the United States is still facing a very dark winter and that a vaccine likely won't be available for months.

Spain to get first Pfizer vaccines in early 2021, Health Minister says

Spain would get the first vaccines against COVID-19 developed by U.S. pharmaceuticals Pfizer and its partner BioNTech in early 2021, Health Minister Salvador Illa said on Tuesday.

Related Videos

Remdesivir shunned in WHO-led COVID study

Biogen Alzheimer's drug closer to approval

Introducing the all-new
Reuters News app

The new Reuters News app is here, redesigned from the ground up to fit your busy life.

Get it now on iOS